Brief: Phio Pharmaceuticals - Announced Departure Of Gerrit Dispersyn From His Role As President And CEO
05/05/2022 13:36
May 5 (Reuters) - Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS - ANNOUNCED DEPARTURE OF GERRIT
DISPERSYN
FROM HIS ROLE AS PRESIDENT AND CEO
* PHIO - GEERT CAUWENBERGH WILL TAKE ON RESPONSIBILITY OF
PRINCIPLE EXECUTIVE OFFICER UNTIL SUCH TIME AS SATISFACTORY
EXECUTIVE SEARCH HAS COMPLETED
Source text for Eikon: ID:nPn1bHnZba
Further company coverage: PHIO.O
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing